EA
TRHC

Emerald Advisers’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Emerald Advisers’s Portfolio TRHC Stock Details TRHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,800
Closed -$72K – 298
2021
Q4 		$72K Buy
+4,800
New +$87.4K ﹤0.01% 249
2021
Q3 		– Sell
-3,106
Closed -$155K – 298
2021
Q2 		$155K Buy
+3,106
New +$139K 0.01% 238
2021
Q1 		– Sell
-92,028
Closed -$3.94M – 303
2020
Q4 		$3.94M Sell
92,028
-132,902
-59% -$5.04M 0.13% 123
2020
Q3 		$9.17M Sell
224,930
-219,189
-49% -$10.9M 0.38% 90
2020
Q2 		$24.3M Buy
444,119
+16,061
+4% +$919K 1.06% 29
2020
Q1 		$22.4M Buy
428,058
+24,636
+6% +$1.33M 1.29% 22
2019
Q4 		$19.6M Buy
403,422
+17,522
+5% +$821K 0.83% 44
2019
Q3 		$21.2M Buy
385,900
+79,797
+26% +$4.57M 0.99% 35
2019
Q2 		$15.3M Buy
306,103
+113,926
+59% +$5.67M 0.61% 69
2019
Q1 		$10.8M Buy
192,177
+1,032
+0.5% +$61.5K 0.44% 86
2018
Q4 		$12.2M Buy
191,145
+12,110
+7% +$858K 0.6% 71
2018
Q3 		$14.5M Sell
179,035
-186,463
-51% -$13.7M 0.53% 88
2018
Q2 		$23.3M Sell
365,498
-13,130
-3% -$644K 0.88% 39
2018
Q1 		$14.7M Sell
378,628
-11,954
-3% -$419K 0.59% 74
2017
Q4 		$11M Sell
390,582
-1,232
-0.3% -$36.1K 0.42% 95
2017
Q3 		$10.5M Sell
391,814
-70
-0% -$1.34K 0.43% 94
2017
Q2 		$5.9M Sell
391,884
-18,990
-5% -$256K 0.25% 107
2017
Q1 		$5.54M Sell
410,874
-510
-0.1% -$7.32K 0.23% 111
2016
Q4 		$6.16M Buy
411,384
+132,844
+48% +$1.7M 0.26% 108
2016
Q3 		$3.99M Buy
+278,540
New +$4.07M 0.18% 146

Other funds holding TRHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Emerald Advisers's TRHC Position: Q1 2022 in Review

Emerald Advisers sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q1 2022, closing a stake of 4,800 shares — an estimated $72K sold.

Emerald Advisers first reported a position in TRHC in Q3 2016 and held it in 20 quarters. The position peaked at $24.3M in Q2 2020. 139 funds tracked by Wall St. Rank hold TRHC as of Q1 2022.

  • Emerald Advisers reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Emerald Advisers sold 4,800 Tabula Rasa HealthCare, Inc. Common Stock shares in Q1 2022, an estimated $72K.
  • Emerald Advisers first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q3 2016 and held it in 20 quarters.
  • Emerald Advisers's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $24.3M in Q2 2020.
  • 139 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q1 2022.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.